BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31509005)

  • 1. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains.
    Allswede DM; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan T; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cannon TD
    Am J Psychiatry; 2020 Feb; 177(2):164-171. PubMed ID: 31509005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study.
    Dwyer DB; Kalman JL; Budde M; Kambeitz J; Ruef A; Antonucci LA; Kambeitz-Ilankovic L; Hasan A; Kondofersky I; Anderson-Schmidt H; Gade K; Reich-Erkelenz D; Adorjan K; Senner F; Schaupp S; Andlauer TFM; Comes AL; Schulte EC; Klöhn-Saghatolislam F; Gryaznova A; Hake M; Bartholdi K; Flatau-Nagel L; Reitt M; Quast S; Stegmaier S; Meyers M; Emons B; Haußleiter IS; Juckel G; Nieratschker V; Dannlowski U; Yoshida T; Schmauß M; Zimmermann J; Reimer J; Wiltfang J; Reininghaus E; Anghelescu IG; Arolt V; Baune BT; Konrad C; Thiel A; Fallgatter AJ; Figge C; von Hagen M; Koller M; Lang FU; Wigand ME; Becker T; Jäger M; Dietrich DE; Scherk H; Spitzer C; Folkerts H; Witt SH; Degenhardt F; Forstner AJ; Rietschel M; Nöthen MM; Mueller N; Papiol S; Heilbronner U; Falkai P; Schulze TG; Koutsouleris N
    JAMA Psychiatry; 2020 May; 77(5):523-533. PubMed ID: 32049274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach.
    Worthington MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Lympus CA; Mathalon DH; Perkins DO; Stone WS; Walker EF; Woods SW; Zhao Y; Cannon TD
    JAMA Psychiatry; 2023 Oct; 80(10):1017-1025. PubMed ID: 37531131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes.
    Deng W; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Walker EF; Cannon TD
    Psychol Med; 2023 Jun; 53(8):3644-3651. PubMed ID: 35144716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.
    Schlosser DA; Jacobson S; Chen Q; Sugar CA; Niendam TA; Li G; Bearden CE; Cannon TD
    Schizophr Bull; 2012 Nov; 38(6):1225-33. PubMed ID: 21825282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program.
    Carrión RE; Correll CU; Auther AM; Cornblatt BA
    Schizophr Bull; 2017 Jan; 43(1):64-74. PubMed ID: 28053131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study.
    Lemos-Giráldez S; Vallina-Fernández O; Fernández-Iglesias P; Vallejo-Seco G; Fonseca-Pedrero E; Paíno-Piñeiro M; Sierra-Baigrie S; García-Pelayo P; Pedrejón-Molino C; Alonso-Bada S; Gutiérrez-Pérez A; Ortega-Ferrández JA
    Schizophr Res; 2009 Dec; 115(2-3):121-9. PubMed ID: 19786339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of measures of functioning for use with treatment-seeking adolescents experiencing attenuated symptoms of psychosis.
    Wilson C; Kline E; Thompson E; Demro C; Pitts S; Bussell K; Reeves GM; Schiffman J
    Early Interv Psychiatry; 2016 Feb; 10(1):81-7. PubMed ID: 25263507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
    Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
    Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
    Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
    Lyngberg K; Buchy L; Liu L; Perkins D; Woods S; Addington J
    Schizophr Res; 2015 Dec; 169(1-3):209-213. PubMed ID: 26589390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premorbid social adjustment and association with attenuated psychotic symptoms in clinical high-risk and help-seeking youth.
    Tarbox-Berry SI; Perkins DO; Woods SW; Addington J
    Psychol Med; 2018 Apr; 48(6):983-997. PubMed ID: 28874223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived social stress and symptom severity among help-seeking adolescents with versus without clinical high-risk for psychosis.
    Millman ZB; Pitts SC; Thompson E; Kline ER; Demro C; Weintraub MJ; DeVylder JE; Mittal VA; Reeves GM; Schiffman J
    Schizophr Res; 2018 Feb; 192():364-370. PubMed ID: 28629890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.